Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

J'CINDA J BITTERS

Allopathic & Osteopathic Physicians Family Medicine

NPI
1104089556
CMS profile
185670
Location
CALDWELL, ID

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$72.67

6 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $72.67 6

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Supernus Pharmaceuticals, Inc. $31.30 2
AstraZeneca Pharmaceuticals LP $27.68 1
PFIZER INC. $13.69 3

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

J'CINDA J BITTERS

NPI 1104089556 · CMS profile ID 185670

Allopathic & Osteopathic Physicians / Family Medicine

CALDWELL, ID

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1104089556?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
J'CINDA J BITTERS, NPI 1104089556, CMS profile ID 185670. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1104089556?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). J'CINDA J BITTERS, NPI 1104089556, CMS profile ID 185670. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1104089556?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
J'CINDA J BITTERS, NPI 1104089556, CMS profile ID 185670, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1104089556?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

6 matching records · $72.67 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 6 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–6 of 6.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $4.8611/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673676467 CMS
AstraZeneca Pharmaceuticals LP $27.6811/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685534546 CMS
PFIZER INC. $4.5810/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673152305 CMS
Supernus Pharmaceuticals, Inc. $11.2406/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702287119 CMS
Supernus Pharmaceuticals, Inc. $20.0603/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702287117 CMS
PFIZER INC. $4.2502/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671927711 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $72.67 6
PY2020 $40.02 3
PY2021 $43.48 3
PY2022 $141.69 7
PY2023 $86.49 7
PY2024 $1,670.51 14
PY2025 $383.26 18

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $4,067.20 3
PY2020 Principal investigator $152,053.84 66
PY2019 Principal investigator $94,886.68 18

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

66 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $25.00 12/30/2020 Non-covered Recipient Entity
ASR LLC
JAK1 DUPILUMAB COMPARATOR STUDY No dispute reported 06/30/2026 742899695
Principal investigator 1 GlaxoSmithKline, LLC. $1,463.40 12/22/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734921933
Principal investigator 1 GlaxoSmithKline, LLC. $1,463.40 12/16/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734911679
Principal investigator 1 GlaxoSmithKline, LLC. $2,015.10 12/16/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734917587
Principal investigator 1 GlaxoSmithKline, LLC. $1,088.10 12/09/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734927755
Principal investigator 1 GlaxoSmithKline, LLC. $2,412.90 11/11/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734927753
Principal investigator 1 GlaxoSmithKline, LLC. $3,168.00 10/14/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734924533
Principal investigator 1 GlaxoSmithKline, LLC. $1,134.90 10/07/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734924327
Principal investigator 1 GlaxoSmithKline, LLC. $1,243.80 09/23/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734908699
Principal investigator 1 GlaxoSmithKline, LLC. $1,134.90 09/23/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734916145
Principal investigator 1 GlaxoSmithKline, LLC. $2,021.40 09/16/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734918529
Principal investigator 1 PFIZER INC. $1,241.60 08/29/2020 Non-covered Recipient Entity
ASR LLC
AN OPENLABEL EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY AND EFFICACY OF PF04965842 IN ADULT PATIENTS WITH MODERATETOSEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 742911057
Principal investigator 1 GlaxoSmithKline, LLC. $1,890.00 08/26/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734918409
Principal investigator 1 GlaxoSmithKline, LLC. $1,703.70 08/12/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734921719
Principal investigator 1 PFIZER INC. $1,369.60 07/31/2020 Non-covered Recipient Entity
ASR LLC
AN OPENLABEL EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY AND EFFICACY OF PF04965842 IN ADULT PATIENTS WITH MODERATETOSEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 742910237
Principal investigator 1 PFIZER INC. $200.00 07/31/2020 Non-covered Recipient Entity
ASR LLC
JAK1 DUPILUMAB COMPARATOR STUDY No dispute reported 06/30/2026 742912023
Principal investigator 1 GlaxoSmithKline, LLC. $1,267.20 07/22/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734921717
Principal investigator 1 PFIZER INC. $2,561.00 07/18/2020 Non-covered Recipient Entity
ASR LLC
JAK1 DUPILUMAB COMPARATOR STUDY No dispute reported 06/30/2026 742909193
Principal investigator 1 PFIZER INC. $140.80 07/17/2020 Non-covered Recipient Entity
ARS LLC
A PHASE 3 CONFIRMATORY STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF04965842 MONOTHERAPY ADMINISTERED TO ADULT PATIENTS WITH MODERATETOSEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 742912363
Principal investigator 1 GlaxoSmithKline, LLC. $1,324.80 07/15/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734910993
Principal investigator 1 GlaxoSmithKline, LLC. $1,473.30 07/15/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734911103
Principal investigator 1 GlaxoSmithKline, LLC. $1,318.50 07/01/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734910369
Principal investigator 1 GlaxoSmithKline, LLC. $1,306.80 06/24/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734904645
Principal investigator 1 GlaxoSmithKline, LLC. $1,473.30 06/24/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734905307
Principal investigator 1 GlaxoSmithKline, LLC. $1,722.60 06/17/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734904771
Principal investigator 1 GlaxoSmithKline, LLC. $1,722.60 06/17/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734910725
Principal investigator 1 GlaxoSmithKline, LLC. $9,264.60 06/10/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734903589
Principal investigator 1 GlaxoSmithKline, LLC. $1,473.30 06/10/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734904961
Principal investigator 1 GlaxoSmithKline, LLC. $6,888.60 06/01/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734902385
Principal investigator 1 PFIZER INC. $875.52 05/16/2020 Non-covered Recipient Entity
ASR LLC
AN OPENLABEL EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY AND EFFICACY OF PF04965842 IN ADULT PATIENTS WITH MODERATETOSEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 742911127
Principal investigator 1 PFIZER INC. $1,301.12 04/23/2020 Non-covered Recipient Entity
ASR LLC
AN OPENLABEL EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY AND EFFICACY OF PF04965842 IN ADULT PATIENTS WITH MODERATETOSEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 742911061
Principal investigator 1 GlaxoSmithKline, LLC. $1,798.20 04/15/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734900761
Principal investigator 1 GlaxoSmithKline, LLC. $1,267.20 04/15/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734902553
Principal investigator 1 GlaxoSmithKline, LLC. $1,496.70 04/08/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734902987
Principal investigator 1 GlaxoSmithKline, LLC. $1,077.30 04/01/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734904037
Principal investigator 1 GlaxoSmithKline, LLC. $1,243.80 03/25/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 753908197
Principal investigator 1 GlaxoSmithKline, LLC. $1,048.50 03/25/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 753908709
Principal investigator 1 GlaxoSmithKline, LLC. $1,107.00 03/25/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 753909009
Principal investigator 1 GlaxoSmithKline, LLC. $5,558.40 03/25/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 753909789
Principal investigator 1 GlaxoSmithKline, LLC. $2,651.40 03/18/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 753908195
Principal investigator 1 GlaxoSmithKline, LLC. $1,641.60 03/18/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 753908707
Principal investigator 1 GlaxoSmithKline, LLC. $1,306.80 03/18/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 753909787
Principal investigator 1 GlaxoSmithKline, LLC. $1,128.60 03/11/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 753908193
Principal investigator 1 GlaxoSmithKline, LLC. $1,000.80 03/11/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 753909005
Principal investigator 1 GlaxoSmithKline, LLC. $1,329.30 03/11/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 753909007
Principal investigator 1 GlaxoSmithKline, LLC. $1,451.70 03/04/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 753909783
Principal investigator 1 GlaxoSmithKline, LLC. $1,383.30 03/04/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 753909785
Principal investigator 1 PFIZER INC. $1,087.24 02/26/2020 Non-covered Recipient Entity
ARS LLC
A PHASE 3 CONFIRMATORY STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF04965842 MONOTHERAPY ADMINISTERED TO ADULT PATIENTS WITH MODERATETOSEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 742909263
Principal investigator 1 GlaxoSmithKline, LLC. $2,690.10 02/25/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734904361
Principal investigator 1 GlaxoSmithKline, LLC. $1,703.70 02/19/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734905949
Principal investigator 1 GlaxoSmithKline, LLC. $1,000.80 02/12/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734905947
Principal investigator 1 GlaxoSmithKline, LLC. $7,668.90 02/12/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734906055
Principal investigator 1 GlaxoSmithKline, LLC. $2,511.00 02/05/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734906333
Principal investigator 1 GlaxoSmithKline, LLC. $2,511.00 02/05/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734912045
Principal investigator 1 PFIZER INC. $2,547.52 02/04/2020 Non-covered Recipient Entity
ASR LLC
AN OPENLABEL EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY AND EFFICACY OF PF04965842 IN ADULT PATIENTS WITH MODERATETOSEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 742912323
Principal investigator 1 GlaxoSmithKline, LLC. $15,608.70 01/23/2020 Non-covered Recipient Entity
ASR LLC
RSV MAT-004 No dispute reported 06/30/2026 734904759
Principal investigator 1 GlaxoSmithKline, LLC. $1,243.80 01/23/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734909545
Principal investigator 1 PFIZER INC. $1,601.60 01/23/2020 Non-covered Recipient Entity
ARS LLC
A PHASE 3 CONFIRMATORY STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF04965842 MONOTHERAPY ADMINISTERED TO ADULT PATIENTS WITH MODERATETOSEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 742909887
Principal investigator 1 GlaxoSmithKline, LLC. $3,248.10 01/22/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734904141
Principal investigator 1 GlaxoSmithKline, LLC. $1,774.80 01/22/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734906053
Principal investigator 1 GlaxoSmithKline, LLC. $1,116.90 01/22/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734906331
Principal investigator 1 GlaxoSmithKline, LLC. $5,392.64 01/21/2020 Non-covered Recipient Entity
ASR LLC
A PHASE IV, 12 WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO C No dispute reported 06/30/2026 734898973
Principal investigator 1 GlaxoSmithKline, LLC. $5,000.00 01/16/2020 Non-covered Recipient Entity
ASR LLC
A PHASE IV, 12 WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO C No dispute reported 06/30/2026 734907979
Principal investigator 1 PFIZER INC. $4,800.00 01/11/2020 Non-covered Recipient Entity
ASR LLC
JAK1 DUPILUMAB COMPARATOR STUDY No dispute reported 06/30/2026 742910589
Principal investigator 1 GlaxoSmithKline, LLC. $5,249.70 01/08/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734901513
Principal investigator 1 GlaxoSmithKline, LLC. $1,116.90 01/08/2020 Non-covered Recipient Entity
ASR LLC
MENB REC 2ND GEN-023 (V72_57) No dispute reported 06/30/2026 734909543